id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-5389-0006,FDA,FDA-2019-E-5389,Determination of Regulatory Review Period for Purposes of Patent Extension; SUNOSI,Notice,Determinations,2021-11-19T05:00:00Z,2021,11,2021-11-19T05:00:00Z,2022-05-19T03:59:59Z,2021-11-19T16:16:11Z,2021-25297,0,0,0900006484e65e47
FDA-2019-E-5389-0005,FDA,FDA-2019-E-5389,Patent Term Extension Approval letter from FDA CDER,Other,Approval,2021-11-05T04:00:00Z,2021,11,2021-11-05T04:00:00Z,,2021-11-05T15:31:14Z,,0,0,0900006484e24dd2
FDA-2019-E-5389-0004,FDA,FDA-2019-E-5389,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T16:57:25Z,,0,0,0900006484c0f022